|
Market Closed -
Nyse
21:00:02 10/02/2026 GMT
|
5-day change
|
1st Jan Change
|
|
117.15 USD
|
-0.42%
|
 |
+1.13%
|
+11.30%
|
|
02-10 |
Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $140 From $135, Maintains Buy Rating
|
MT
| |
02-06 |
Guggenheim Adjusts Price Target on Merck & Co to $140 From $122, Maintains Buy Rating
|
MT
| |
02-05 |
Analyst recommendations: Corteva, Snap, Alphabet, Eli Lilly, PayPal, Qualcomm…
|  | |
02-04 |
Merck's Pipeline Progress and Business Development Strategy Remain in Focus, Morgan Stanley Says
|
MT
| |
02-04 |
Bernstein Adjusts Price Target on Merck to $100 From $95, Maintains Market Perform Rating
|
MT
| |
02-04 |
Leerink Partners Adjusts Price Target on Merck to $128 From $124, Maintains Outperform Rating
|
MT
| |
02-04 |
Goldman Sachs Adjusts Price Target on Merck to $133 From $120, Maintains Buy Rating
|
MT
| |
02-04 |
BMO Capital Adjusts Price Target on Merck & Co. to $135 From $130, Maintains Outperform Rating
|
MT
| |
02-04 |
Scotiabank Adjusts PT on Merck & Co. to $136 From $120, Maintains Sector Outperform Rating
|
MT
| |
02-04 |
Morgan Stanley Adjusts Price Target on Merck & Co. to $109 From $101, Maintains Equalweight Rating
|
MT
| |
02-04 |
Wells Fargo Adjusts Price Target on Merck & Co. to $135 From $125, Maintains Overweight Rating
|
MT
| |
02-04 |
Cantor Fitzgerald Adjusts Price Target on Merck & Co. to $120 From $116, Maintains Neutral Rating
|
MT
| |
02-04 |
Citigroup Adjusts Price Target on Merck & Co to $120 From $115, Maintains Neutral Rating
|
MT
| |
02-03 |
Scotiabank Raises Merck Price Target to $136 From $120
|
MT
| |
01-27 |
Cantor Fitzgerald Adjusts Price Target on Merck & Co. to $116 From $83, Keeps Neutral Rating
|
MT
| |
01-27 |
Citigroup Adjusts Price Target on Merck & Co. to $115 From $110, Keeps Neutral Rating
|
MT
| |
01-26 |
Berenberg Raises Price Target on Merck to $115 From $95, Keeps Hold Rating
|
MT
| |
01-26 |
Analyst recommendations: Amazon, Intel, Netflix, Merck, SanDisk…
| | |
01-22 |
JPMorgan Adjusts Price Target on Merck & Co. to $125 From $120, Maintains Overweight Rating
|
MT
| |
01-20 |
TD Cowen Adjusts Price Target on Merck to $120 From $100, Maintains Hold Rating
|
MT
| |
01-20 |
Leerink Partners Adjusts Price Target on Merck to $124 From $114, Maintains Outperform Rating
|
MT
| |
01-09 |
Morgan Stanley Adjusts Price Target on Merck to $101 From $102, Maintains Equalweight Rating
|
MT
| |
01-09 |
Morgan Stanley Trims Price Target on Merck to $101 From $102, Keeps Equalweight Rating
|
MT
| |
01-08 |
Merck Shares Rise After Wolfe Research Upgrade
|
MT
| |
01-08 |
Rothschild & Co Redburn Adjusts Merck Price Target to $135 From $125, Maintains Buy Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
